INSMED Inc — Director's Dealing 2025

Jul 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-07-01

Reporting Person: Lewis William (Director, Chair and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-07-01	Common Stock	M	6830	$10.85	Acquired	240754	Indirect
2025-07-01	Common Stock	S	3666	$97.73	Disposed	237088	Indirect
2025-07-01	Common Stock	S	2349	$98.83	Disposed	234739	Indirect
2025-07-01	Common Stock	S	815	$99.61	Disposed	233924	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-07-01	Stock Option (right to buy)	$10.85	M	6830	Disposed	2026-05-19	Common Stock (6830)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	303911	Direct
Common Stock	50500	Indirect

Footnotes

F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: This is the weighted average sales price representing 3,666 shares sold at prices ranging from $97.40 to $98.38 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3: This is the weighted average sales price representing 2,349 shares sold at prices ranging from $98.40 to $99.39 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F4: This is the weighted average sales price representing 815 shares sold at prices ranging from $99.40 to $100.26 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F5: Includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

F6: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.